Comments on:

Drug firms argue against $1.2B Arkansas judgment

Back to the article » |
LITTLE ROCK, Ark. (AP) — A lawyer for two drug companies told the Arkansas Supreme Court that the state improperly relied on federal regulations in a lawsuit that resulted in a $1.2 billion award over the companies' marketing of an antipsychotics drug. The state's attorneys countered during Thursday's hearing before the high court that Johnson & Johnson and a subsidiary were properly penalized...

To learn more about commenting on and our community guidelines, please see our comments FAQ.